Cargando…
Effect of Increasing Age on Brain Dysfunction in Cirrhosis
Patients with cirrhosis are growing older, which could have an impact on brain dysfunction beyond hepatic encephalopathy. Our aim was to study the effect of concomitant aging and cirrhosis on brain inflammation and degeneration using human and animal experiments. For the human study, age‐matched pat...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312655/ https://www.ncbi.nlm.nih.gov/pubmed/30619995 http://dx.doi.org/10.1002/hep4.1286 |
_version_ | 1783383809508507648 |
---|---|
author | Liu, Runping Ahluwalia, Vishwadeep Kang, Jason D. Ghosh, Siddhartha S. Zhou, Huiping Li, Yunzhou Zhao, Derrick Gurley, Emily Li, Xiaojiaoyang White, Melanie B. Fagan, Andrew Lippman, H. Robert Wade, James B. Hylemon, Phillip B. Bajaj, Jasmohan S. |
author_facet | Liu, Runping Ahluwalia, Vishwadeep Kang, Jason D. Ghosh, Siddhartha S. Zhou, Huiping Li, Yunzhou Zhao, Derrick Gurley, Emily Li, Xiaojiaoyang White, Melanie B. Fagan, Andrew Lippman, H. Robert Wade, James B. Hylemon, Phillip B. Bajaj, Jasmohan S. |
author_sort | Liu, Runping |
collection | PubMed |
description | Patients with cirrhosis are growing older, which could have an impact on brain dysfunction beyond hepatic encephalopathy. Our aim was to study the effect of concomitant aging and cirrhosis on brain inflammation and degeneration using human and animal experiments. For the human study, age‐matched patients with cirrhosis and controls between 65 and 85 years underwent cognitive testing, quality of life (QOL) assessment, and brain magnetic resonance (MR) spectroscopy and resting state functional MR imaging (rs‐fMRI) analysis. Data were compared between groups. For the animal study, young (10‐12 weeks) and old (1.5 years) C57BL/6 mice were given either CCl(4) gavage to develop cirrhosis or a vehicle control and were followed for 12 weeks. Cortical messenger RNA (mRNA) expression of inflammatory mediators (interleukin [IL]‐6, IL‐1β, transforming growth factor β [TGF‐β], and monocyte chemoattractant protein 1), sirtuin‐1, and gamma‐aminobutyric acid (GABA)‐ergic synaptic plasticity (neuroligin‐2 [NLG2], discs large homolog 4 [DLG4], GABA receptor, subunit gamma 1/subunit B1 [GABRG1/B1]) were analyzed and compared between younger/older control and cirrhotic mice. The human study included 46 subjects (23/group). Patients with cirrhosis had worse QOL and cognition. On MR spectroscopy, patients with cirrhosis had worse changes related to ammonia and lower N‐acetyl aspartate, whereas rs‐fMRI analysis revealed that these patients demonstrated functional connectivity changes in the frontoparietal cortical region compared to controls. Results of the animal study showed that older mice required lower CCl(4) to reach cirrhosis. Older mice, especially with cirrhosis, demonstrated higher cortical inflammatory mRNA expression of IL‐6, IL‐1β, and TGF‐β; higher glial and microglial activation; and lower sirtuin‐1 expression compared to younger mice. Older mice also had lower expression of DLG4, an excitatory synaptic organizer, and higher NLG2 and GABRG1/B1 receptor expression, indicating a predominantly inhibitory synaptic organization. Conclusion: Aging modulates brain changes in cirrhosis; this can affect QOL, cognition, and brain connectivity. Cortical inflammation, microglial activation, and altered GABA‐ergic synaptic plasticity could be contributory. |
format | Online Article Text |
id | pubmed-6312655 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-63126552019-01-07 Effect of Increasing Age on Brain Dysfunction in Cirrhosis Liu, Runping Ahluwalia, Vishwadeep Kang, Jason D. Ghosh, Siddhartha S. Zhou, Huiping Li, Yunzhou Zhao, Derrick Gurley, Emily Li, Xiaojiaoyang White, Melanie B. Fagan, Andrew Lippman, H. Robert Wade, James B. Hylemon, Phillip B. Bajaj, Jasmohan S. Hepatol Commun Original Articles Patients with cirrhosis are growing older, which could have an impact on brain dysfunction beyond hepatic encephalopathy. Our aim was to study the effect of concomitant aging and cirrhosis on brain inflammation and degeneration using human and animal experiments. For the human study, age‐matched patients with cirrhosis and controls between 65 and 85 years underwent cognitive testing, quality of life (QOL) assessment, and brain magnetic resonance (MR) spectroscopy and resting state functional MR imaging (rs‐fMRI) analysis. Data were compared between groups. For the animal study, young (10‐12 weeks) and old (1.5 years) C57BL/6 mice were given either CCl(4) gavage to develop cirrhosis or a vehicle control and were followed for 12 weeks. Cortical messenger RNA (mRNA) expression of inflammatory mediators (interleukin [IL]‐6, IL‐1β, transforming growth factor β [TGF‐β], and monocyte chemoattractant protein 1), sirtuin‐1, and gamma‐aminobutyric acid (GABA)‐ergic synaptic plasticity (neuroligin‐2 [NLG2], discs large homolog 4 [DLG4], GABA receptor, subunit gamma 1/subunit B1 [GABRG1/B1]) were analyzed and compared between younger/older control and cirrhotic mice. The human study included 46 subjects (23/group). Patients with cirrhosis had worse QOL and cognition. On MR spectroscopy, patients with cirrhosis had worse changes related to ammonia and lower N‐acetyl aspartate, whereas rs‐fMRI analysis revealed that these patients demonstrated functional connectivity changes in the frontoparietal cortical region compared to controls. Results of the animal study showed that older mice required lower CCl(4) to reach cirrhosis. Older mice, especially with cirrhosis, demonstrated higher cortical inflammatory mRNA expression of IL‐6, IL‐1β, and TGF‐β; higher glial and microglial activation; and lower sirtuin‐1 expression compared to younger mice. Older mice also had lower expression of DLG4, an excitatory synaptic organizer, and higher NLG2 and GABRG1/B1 receptor expression, indicating a predominantly inhibitory synaptic organization. Conclusion: Aging modulates brain changes in cirrhosis; this can affect QOL, cognition, and brain connectivity. Cortical inflammation, microglial activation, and altered GABA‐ergic synaptic plasticity could be contributory. John Wiley and Sons Inc. 2018-11-30 /pmc/articles/PMC6312655/ /pubmed/30619995 http://dx.doi.org/10.1002/hep4.1286 Text en © 2018 The Authors. Hepatology Communications published by Wiley Periodicals, Inc., on behalf of the American Association for the Study of Liver Diseases. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Liu, Runping Ahluwalia, Vishwadeep Kang, Jason D. Ghosh, Siddhartha S. Zhou, Huiping Li, Yunzhou Zhao, Derrick Gurley, Emily Li, Xiaojiaoyang White, Melanie B. Fagan, Andrew Lippman, H. Robert Wade, James B. Hylemon, Phillip B. Bajaj, Jasmohan S. Effect of Increasing Age on Brain Dysfunction in Cirrhosis |
title | Effect of Increasing Age on Brain Dysfunction in Cirrhosis |
title_full | Effect of Increasing Age on Brain Dysfunction in Cirrhosis |
title_fullStr | Effect of Increasing Age on Brain Dysfunction in Cirrhosis |
title_full_unstemmed | Effect of Increasing Age on Brain Dysfunction in Cirrhosis |
title_short | Effect of Increasing Age on Brain Dysfunction in Cirrhosis |
title_sort | effect of increasing age on brain dysfunction in cirrhosis |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312655/ https://www.ncbi.nlm.nih.gov/pubmed/30619995 http://dx.doi.org/10.1002/hep4.1286 |
work_keys_str_mv | AT liurunping effectofincreasingageonbraindysfunctionincirrhosis AT ahluwaliavishwadeep effectofincreasingageonbraindysfunctionincirrhosis AT kangjasond effectofincreasingageonbraindysfunctionincirrhosis AT ghoshsiddharthas effectofincreasingageonbraindysfunctionincirrhosis AT zhouhuiping effectofincreasingageonbraindysfunctionincirrhosis AT liyunzhou effectofincreasingageonbraindysfunctionincirrhosis AT zhaoderrick effectofincreasingageonbraindysfunctionincirrhosis AT gurleyemily effectofincreasingageonbraindysfunctionincirrhosis AT lixiaojiaoyang effectofincreasingageonbraindysfunctionincirrhosis AT whitemelanieb effectofincreasingageonbraindysfunctionincirrhosis AT faganandrew effectofincreasingageonbraindysfunctionincirrhosis AT lippmanhrobert effectofincreasingageonbraindysfunctionincirrhosis AT wadejamesb effectofincreasingageonbraindysfunctionincirrhosis AT hylemonphillipb effectofincreasingageonbraindysfunctionincirrhosis AT bajajjasmohans effectofincreasingageonbraindysfunctionincirrhosis |